T&R Biofab Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.12%

T&R Biofab Co. Ltd (246710) has an Asset Resilience Ratio of 0.12% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 246710 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩100.00 Million
≈ $67.77K USD Cash + Short-term Investments

Total Assets

₩83.86 Billion
≈ $56.83 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how T&R Biofab Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of T&R Biofab Co. Ltd.

Liquid Assets Composition Over Time

This chart breaks down T&R Biofab Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of T&R Biofab Co. Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩100.00 Million 0.12%
Total Liquid Assets ₩100.00 Million 0.12%

Asset Resilience Insights

  • Limited Liquidity: T&R Biofab Co. Ltd maintains only 0.12% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

T&R Biofab Co. Ltd Industry Peers by Asset Resilience Ratio

Compare T&R Biofab Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for T&R Biofab Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for T&R Biofab Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 17.55% ₩17.28 Billion
≈ $11.71 Million
₩98.45 Billion
≈ $66.72 Million
-34.30pp
2023-12-31 51.84% ₩51.75 Billion
≈ $35.07 Million
₩99.82 Billion
≈ $67.64 Million
-1.39pp
2022-12-31 53.23% ₩40.42 Billion
≈ $27.39 Million
₩75.94 Billion
≈ $51.46 Million
-17.50pp
2021-12-31 70.73% ₩58.17 Billion
≈ $39.42 Million
₩82.23 Billion
≈ $55.73 Million
-5.30pp
2020-12-31 76.03% ₩36.88 Billion
≈ $24.99 Million
₩48.51 Billion
≈ $32.87 Million
-4.17pp
2019-12-31 80.20% ₩21.72 Billion
≈ $14.72 Million
₩27.09 Billion
≈ $18.36 Million
-11.94pp
2018-12-31 92.13% ₩28.66 Billion
≈ $19.42 Million
₩31.10 Billion
≈ $21.08 Million
+9.69pp
2017-12-31 82.44% ₩7.80 Billion
≈ $5.29 Million
₩9.47 Billion
≈ $6.42 Million
-1.57pp
2016-12-31 84.01% ₩8.06 Billion
≈ $5.46 Million
₩9.59 Billion
≈ $6.50 Million
--
pp = percentage points

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices
Market Cap
$47.03 Million
₩69.40 Billion KRW
Market Cap Rank
#22220 Global
#1401 in Korea
Share Price
₩2275.00
Change (1 day)
+0.22%
52-Week Range
₩1194.00 - ₩4535.00
All Time High
₩44150.00
About

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.